Main Profile
Pharmacovigilance Service Provider
Description in a few words:
Supplying drug benefit/risk evaluation service through data collection, literature screening and preparation of relevant reports to pharmaceutical companies. Holds partial or all pharmacovigilance responsibilities of the companies to the health authority.
Founder:
Dr. Seyfullah Dağıstanlı
Current Leadership:
Tayfun Erdönmez, General Manager
Founding Year:
2011
“After working in the private sector, I realized that many local companies lack knowledge in terms of managing their responsibilities in this field. Small companies may not have the budget to invest in and implement a sound system. It was clear that local companies needed the assistance of experts. As a result, the market for contracted pharmacovigilance service companies emerged.”
Services
174 companies outsourcing all of their pharmacovigilance responsibilities to DeltaPV
Number of pharmaceutical products responsible for:
4500+
R&D
R&D focus
VigidataPV software system that is used for collection and sorting out pharmacovigilance data.
Exports
Export % in revenues:
10%
List of export countries:
More than 55 countries in total, mainly: Ireland, Kazakhstan, Belarus, Egypt, UAE, Jordan, Lebanon, Croatia and other countries from MENA/CIS region
In More Depth
Official license of health authority for pharmacovigilance service provision:
Revenue or Growth Rate in past financial year:
15%
USP/ or a differentiating fact:
First company to provide pharmacovigilance services.
Pharmacovigilance service provider with the most in-depth data collection service thank to its software Vigidata.
Prominent partnerships/ clients
174+ pharmaceutical companies: Abbott, Abbvie, Baxter, Bayer, Gen İlaç, Shire, Novo Nordisk, P&G, Novartis, World Medicine and more.
Contact:
Website:
E-mail: